薬剤比較
Semaglutide vs Tolazamide
Semaglutide vs Tolazamide for T2D: GLP-1 agonist vs first-gen sulfonylurea. Compare A1c, weight loss, CV benefits vs hypoglycemia risk and older agent.
このページには比較できる項目がありません。
臨床的背景
This comparison is relevant when considering a modern GLP-1 agonist versus an older first-generation sulfonylurea for type 2 diabetes, often in cost or access-constrained settings.
結論
Semaglutide is generally preferred for broader metabolic and CV benefits, while Tolazamide may be considered where cost is a major barrier with close monitoring.
すべての薬剤比較